Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of PB-119 injection in Chinese subjects with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PB-119 (PB-119)

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Obesity | Phase 1, Phase 2 | Status: COMPLETED